Yingbin Xie
Overview
Explore the profile of Yingbin Xie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weng Z, Luo W, Li L, Kong Q, Luo J, Xie Y, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
. 2024 Nov;
40(11):1005-1010.
PMID: 39566526
Objective To investigate the efficacy and safety of Xihuang capsules as an adjuvant treatment for metastatic colorectal cancer and their impact on immune function. Methods A retrospective analysis was conducted...
2.
Xie Y, Chen L, Zhou J, Yang C, Xu C, Fan X, et al.
Cancer Biol Med
. 2020 Sep;
17(3):664-675.
PMID: 32944398
Mesenchymal subtype of glioblastoma (mesGBM) is a refractory disease condition characterized by therapeutic failure and tumor recurrence. Hyperactive transforming growth factor-β (TGF-β) signaling could be a signature event in mesGBM,...
3.
Xie Y, Tan Y, Yang C, Zhang X, Xu C, Qiao X, et al.
Cancer Biol Med
. 2020 Jan;
16(4):784-796.
PMID: 31908895
Objective: ATRX is a multifunctional protein that is tightly regulated by and implicated in transcriptional regulation and chromatin remodeling. Numerous studies have shown that genetic alterations in ATRX play a...
4.
Yang C, Tan Y, Li S, Zhou J, Wang Q, Wang Y, et al.
Aging (Albany NY)
. 2019 Dec;
11(23):11224-11243.
PMID: 31822636
Glioblastoma is a highly aggressive brain malignancy with a poor prognosis. Its high intratumor heterogeneity contributes to therapeutic resistance, tumor progression and recurrence. We sequenced 31 loci in 11 patients...
5.
Tan Y, Wang Q, Xie Y, Qiao X, Zhang S, Wang Y, et al.
Int J Oncol
. 2018 Oct;
54(1):87-97.
PMID: 30365046
The present study aimed to identify the therapeutic role of the forkhead box M1 (FOXM1)‑associated pathway in triple‑negative breast cancer (TNBC). Using a Cancer Landscapes‑based analysis, a gene regulatory network...